HomeOwner SearchCategory Search
Visit USCOAntibody and Peptide Conjugate Based Potential Diagnostic and Therapeutic Agents
Text Registration
Copyright Title
Antibody and Peptide Conjugate Based Potential Diagnostic and Therapeutic Agents
Status
Published
on 13 Mar 2019
Year of Creation
2018
Copyright Claimant
Sen Zhang
Registration Number
TX0008691502
on 13 Mar 2019Copyright Summary
The U.S. Copyright record (Registration Number: TX0008691502) dated 13 Mar 2019, pertains to an electronic file (eService) titled "Antibody and Peptide Conjugate Based Potential Diagnostic and Therapeutic Agents" created in 2018. The copyright holder is Sen Zhang, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Sen Zhang.
Application Details
Registration Number
TX0008691502
Registration Date
3/13/2019
Year of Creation
2018
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Antibody and Peptide Conjugate Based Potential Diagnostic and Therapeutic Agents
Author Statement: Sen Zhang Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.